Neurodevelopmental Disorders: Studying the Clinical Impact of Genomic Sequencing
May 2, 2016•8 min
Neurodevelopmental disorders, such as intellectual disability, Tourette syndrome, autism and neuromuscular diseases affect more than 10 percent of children. Recent advances in genomic medicine are unraveling the etiology of these disorders and providing answers to more patients and families. These discoveries, along with advances in pharmacogenomics are the foundation of precision medicine. This topic is important to many and is an area of focus regarding active studies being conducted within the Genome Center. Hear from Sarah Soden, MD, on GSEND (Genomic Sequencing for the Etiology of Neurodevelopmental Disorders) a prospective study designed to determine whether genomic sequencing early in a child’s diagnostic evaluation improves diagnoses and transforms outcomes.